Three-year key project receives 560,000 euros in funding
Researchers at the Institute of Pharmacy and Molecular Biotechnology of Heidelberg University are exploring new approaches to the treatment of diseases of the central nervous system such as Alzheimer's and brain tumours. In collaboration with a research team from the USA, Prof. Dr. Gert Fricker in the field of pharmaceutical technology and neurobiologist Prof. Dr. Ulrike Müller are developing transport systems that can penetrate the blood-brain barrier to "ferry" certain agents into the brain. The Else Kröner-Fresenius Foundation is funding the three-year key project with approximately 560,000 euros. Research work is scheduled to begin in April 2016.
The blood-brain barrier, which separates the central nervous system from circulating blood, is formed by the vascular walls of the cerebral capillaries and allows the free passage of only a few nutrients. The barrier is virtually impermeable especially to macromolecules like proteins, DNA and RNA. Yet it is precisely these molecules, known as biologicals, that Prof. Fricker indicates are highly interesting for treating Alzheimer's and aggressive brain tumours, the glioblastomas.
His working group has now developed special polymer nanoparticles with a modified surface that enables them to specifically dock onto and permeate the blood-brain barrier, after which they dissolve in the brain. Prof. Fricker explains that these particles can be loaded with low molecular agents, i.e., substances of low molecular weight. The particles then transport the otherwise disallowed substances into the central nervous system, where they reach the therapeutically necessary concentrations.
The underlying concept is now being applied to biologicals provided by Prof. Müller and her colleague Prof. Dr. Olivia Merkel of Wayne State University Detroit (USA). Ulrike Müller specialises in Alzheimer’s research. The Heidelberg neurobiologists and her working group supply the peptide APPsα, which protects the nerve cells and acts as an antagonist to the toxic ß amyloid. The ß amyloid deposits are thought to be one of the main causes of Alzheimer’s disease. Olivia Merkel and her research team are supplying the so-called small interfering RNA molecules. These short molecules of ribonucleic acid help turn off the expression of certain genes in brain tumours.
The charitable Else Kröner-Fresenius Foundation promotes the advancement of medical research. The foundation supports key projects with the potential to make fundamental and groundbreaking discoveries that could impact an entire field of research.
Prof. Dr. Gert Fricker and Prof. Dr. Ulrike Müller
Institute of Pharmacy and Molecular Biotechnology
Phone: +49 6221 54-8336 (Fricker) and -6717 (Müller)
Communications and Marketing
Press Office, phone: +49 6221 54-2311
Marietta Fuhrmann-Koch | idw - Informationsdienst Wissenschaft
How cheetahs stay fit and healthy
24.03.2017 | Forschungsverbund Berlin e.V.
When Air is in Short Supply - Shedding light on plant stress reactions when oxygen runs short
23.03.2017 | Institut für Pflanzenbiochemie
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
24.03.2017 | Earth Sciences
24.03.2017 | Health and Medicine
24.03.2017 | Earth Sciences